Quincy C. Moore

421 total citations
21 papers, 341 citations indexed

About

Quincy C. Moore is a scholar working on Ophthalmology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Quincy C. Moore has authored 21 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Ophthalmology, 7 papers in Epidemiology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Quincy C. Moore's work include Ocular Infections and Treatments (11 papers), Pneumonia and Respiratory Infections (7 papers) and Streptococcal Infections and Treatments (7 papers). Quincy C. Moore is often cited by papers focused on Ocular Infections and Treatments (11 papers), Pneumonia and Respiratory Infections (7 papers) and Streptococcal Infections and Treatments (7 papers). Quincy C. Moore collaborates with scholars based in United States and France. Quincy C. Moore's co-authors include Larry S. McDaniel, Mary E. Marquart, Melissa Sanders, Afshin Shafiee, Chinwendu Onwubiko, Jonathan Fratkin, Stephanie Carmicle, Hilary W. Thompson, Tony Grady and Christine M. Sanfilippo and has published in prestigious journals such as Infection and Immunity, Vaccine and Investigative Ophthalmology & Visual Science.

In The Last Decade

Quincy C. Moore

21 papers receiving 334 citations

Peers

Quincy C. Moore
Ahmad Elsahn United Kingdom
Henri Sueke United Kingdom
Malcolm Armstrong United Kingdom
Lottie Brown United Kingdom
Ahmad Elsahn United Kingdom
Quincy C. Moore
Citations per year, relative to Quincy C. Moore Quincy C. Moore (= 1×) peers Ahmad Elsahn

Countries citing papers authored by Quincy C. Moore

Since Specialization
Citations

This map shows the geographic impact of Quincy C. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quincy C. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quincy C. Moore more than expected).

Fields of papers citing papers by Quincy C. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quincy C. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quincy C. Moore. The network helps show where Quincy C. Moore may publish in the future.

Co-authorship network of co-authors of Quincy C. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Quincy C. Moore. A scholar is included among the top collaborators of Quincy C. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quincy C. Moore. Quincy C. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kandhola, Gurshagan, et al.. (2023). Fabrication of Chitosan/PEGDA Bionanocomposites for Enhanced Drug Encapsulation and Release Efficiency. Molecular Pharmaceutics. 20(11). 5532–5542. 7 indexed citations
2.
Moore, Quincy C., et al.. (2021). Using a Mock Trial to Teach Science and the Law. Journal of Political Science Education. 18(1). 81–92. 4 indexed citations
3.
Solomon, Olivia, et al.. (2020). Study of Pneumococcal Surface Protein, PspA, Incorporated in Poly(Vinyl Alcohol) Hydrogel Membranes. Journal of Biomaterials and Nanobiotechnology. 11(1). 67–81. 1 indexed citations
4.
Grady, Tony, et al.. (2020). Development and Characterization of Membranes with PVA Containing Silver Particles: A Study of the Addition and Stability. Polymers. 12(9). 1937–1937. 26 indexed citations
5.
Thompson, Hilary W., et al.. (2013). Modulation of Immune Signaling, Bacterial Clearance, and Corneal Integrity by Toll-like Receptors duringStreptococcus pneumoniaeKeratitis. Current Eye Research. 38(10). 1036–1048. 10 indexed citations
6.
Sanders, Melissa, et al.. (2013). Passive immunization with Pneumovax®23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis. BMC Ophthalmology. 13(1). 8–8. 9 indexed citations
7.
Sanders, Melissa, et al.. (2011). Pathogenesis of A Clinical Ocular Strain of Streptococcus pneumoniae and the Interaction of Pneumolysin with Corneal Cells. Journal of Bacteriology & Parasitology. 2(2). 108–108. 17 indexed citations
8.
Sanders, Melissa, Quincy C. Moore, Moon H. Nahm, et al.. (2011). Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine forStreptococcus pneumoniaeKeratitis. Investigative Ophthalmology & Visual Science. 52(12). 9232–9232. 15 indexed citations
9.
Sanders, Melissa, Quincy C. Moore, Christine M. Sanfilippo, et al.. (2010). Comparative Efficacy of Besifloxacin and Other Fluoroquinolones in a Prophylaxis Model of Penicillin-Resistant Streptococcus pneumoniae Rabbit Endophthalmitis. Journal of Ocular Pharmacology and Therapeutics. 26(3). 237–243. 5 indexed citations
10.
Sanders, Melissa, et al.. (2010). Immunization with Pneumolysin Protects Against Both Retinal and Global Damage Caused by Streptococcus pneumoniae Endophthalmitis. Journal of Ocular Pharmacology and Therapeutics. 26(6). 571–577. 17 indexed citations
11.
Sanders, Melissa, et al.. (2010). Efficacy of Besifloxacin in an Early Treatment Model of Methicillin-Resistant Staphylococcus Aureus Keratitis. Journal of Ocular Pharmacology and Therapeutics. 26(2). 193–198. 19 indexed citations
12.
Sanders, Melissa, et al.. (2010). The Streptococcus pneumoniae Capsule Is Required for Full Virulence in Pneumococcal Endophthalmitis. Investigative Ophthalmology & Visual Science. 52(2). 865–872. 30 indexed citations
13.
Sanders, Melissa, Quincy C. Moore, Christine M. Sanfilippo, et al.. (2010). Comparison of Besifloxacin, Gatifloxacin, and Moxifloxacin Against Strains of Pseudomonas aeruginosa With Different Quinolone Susceptibility Patterns in a Rabbit Model of Keratitis. Cornea. 30(1). 83–90. 17 indexed citations
14.
Moore, Quincy C., Chinwendu Onwubiko, Melissa Sanders, et al.. (2009). Development of a <i>Streptococcus pneumoniae </i>Keratitis Model in Mice. Ophthalmic Research. 42(3). 141–146. 10 indexed citations
15.
Sanders, Melissa, et al.. (2009). Efficacy of Besifloxacin in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Keratitis. Cornea. 28(9). 1055–1060. 27 indexed citations
16.
Sanders, Melissa, Quincy C. Moore, Armando R. Caballero, et al.. (2008). Protection fromStreptococcus pneumoniaeKeratitis by Passive Immunization with Pneumolysin Antiserum. Investigative Ophthalmology & Visual Science. 49(1). 290–290. 13 indexed citations
17.
Moore, Quincy C., et al.. (2007). Pneumolysin, PspA, and PspC Contribute to Pneumococcal Evasion of Early Innate Immune Responses during Bacteremia in Mice. Infection and Immunity. 75(4). 2067–2070. 43 indexed citations
18.
Onwubiko, Chinwendu, et al.. (2007). Factor H Binding to PspC ofStreptococcus pneumoniaeIncreases Adherence to Human Cell Lines In Vitro and Enhances Invasion of Mouse Lungs In Vivo. Infection and Immunity. 75(8). 4082–4087. 41 indexed citations
19.
Moore, Quincy C., et al.. (2007). Immunization with PspA Incorporated into a Poly(Ethylene Oxide) Matrix Elicits Protective Immunity against Streptococcus pneumoniae. Clinical and Vaccine Immunology. 14(6). 789–791. 4 indexed citations
20.
Moore, Quincy C., et al.. (2006). Enhanced protective immunity against pneumococcal infection with PspA DNA and protein. Vaccine. 24(29-30). 5755–5761. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026